$HKPD News

Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split

Cellyan Biotechnology Announces 1-For-20 Reverse Stock Split, Effective Oct. 26

Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

Cellyan Biotechnology Granted 180‑Day Nasdaq Extension To Regain Compliance

Cellyan Biotechnology Files Prospectus For $200M Mixed Shelf

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

Cellyan Biotechnology Receives Nasdaq Notice

Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders

One Hong Kong Pharma Digital Technology Holdings Insider Raised Their Stake In The Previous Year

12 Industrials Stocks Moving In Friday's Intraday Session

Is Hong Kong Pharma Digital Technology Holdings Limited's (NASDAQ:HKPD) 36% ROE Better Than Average?

Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024

Hong Kong Pharma Digital Technology Holdings Financial Results For Six Months Ended September 30: Net Revenues Total $11.09M Up 58.9% YoY; Achieved Net Income Of $828,559, Up 232.6% YoY

Hong Kong Pharma Digital Technology Holdings Financial Results For Six Months Ended September 30: Net Revenues Total $11.09M Up 58.9% YoY; Achieved Net Income Of $828,559, Up 232.6% YoY

Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering

Hong Kong Pharma Digital Technology IPO Opens For Trade At $3.50/Share; IPO Priced At $4/Share

Hong Kong Pharma Digital Technology IPO Indicating $2.76 On 64K Shares

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation